{"mainPropery":{"diseaseId":9783,"diseaseName":"Human T-cell leukemia virus type 2","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9783/human-t-cell-leukemia-virus-type-2","synonyms":["HTLV-2","Human T lymphotropic virus type 2"],"synonyms-with-source":[{"name":"HTLV-2"},{"name":"Human T lymphotropic virus type 2"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":25,"diseaseTypeName":"Viral infections"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Human%20T-cell%20leukemia%20virus%20type%202%5BTitle/Abstract%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Human T-cell leukemia virus type 2. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Human+T-cell+leukemia+virus+type+2%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Human T-cell leukemia virus type 2. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/219285-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":8087,"questionText":"What is human T-cell leukemia virus, type 2?","answerText":"<strong>Human T-cell leukemia virus, type 2 (HTLV-2) </strong>is a <a href=\"http://ghr.nlm.nih.gov/glossary=retrovirus\" target=\"_blank\">retroviral</a> infection that affect the T cells (a type of white blood cell). Although this virus generally causes no signs or symptoms, scientists suspect that some affected people may later develop neurological&nbsp;problems and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a> lung infections. HTLV-2 is spread by blood transfusions, sexual contact and sharing needles. It can also be spread from mother to child during birth or breast-feeding.[7945][7946] There is no cure or treatment for HTLV-2 and it is considered a lifelong condition; however, most infected people remain <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002217.htm\" target=\"_blank\">asymptomatic</a> (show no symptoms) throughout life.[7946]","dateModified":"2014-12-31T19:58:00"},"basicQuestions":[{"questionId":8088,"questionText":"What are the signs and symptoms of human T-cell leukemia virus, type 2?","answerText":"Human T-cell leukemia virus, type 2 (HTLV-2) generally causes no signs or symptoms. Although HTLV-2 has not been definitively linked with any specific health problems, scientists suspect that some affected people may later develop neurological problems such as:[7945][7946]\r\n<ul>\r\n    <li>Sensory neuropathies (conditions that affect the nerves that provide feeling) </li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003199.htm\" target=\"_blank\">Gait abnormalities</a></li>\r\n    <li>Bladder dysfunction</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/mildcognitiveimpairment.html\" target=\"_blank\">Mild cognitive impairment</a></li>\r\n    <li>Motor abnormalities (loss of or limited muscle control or movement, or limited mobility)</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003164.htm\" target=\"_blank\">Erectile dysfunction</a></li>\r\n</ul>\r\n<br />\r\nAlthough evidence is limited, there may also be a link between HTLV-2 and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a> lung infections (i.e. pneumonia and bronchitis), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001243.htm\" target=\"_blank\">arthritis</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000141.htm\" target=\"_blank\">asthma</a>, and <a href=\"http://www.mayoclinic.org/diseases-conditions/dermatitis-eczema/basics/definition/con-20032183\" target=\"_blank\">dermatitis</a>.[7946]","dateModified":"2014-12-31T20:31:00","resourceClassificationName":"Symptoms","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8089,"questionText":"What causes human T-cell leukemia virus, type 2?","answerText":"Human T-cell leukemia virus, type 2 (HTLV-2) occurs when a person is infected by the human T-cell leukemia <a href=\"http://ghr.nlm.nih.gov/glossary=retrovirus\" target=\"_blank\">retrovirus</a>. HTLV-2 is spread by blood transfusions, sexual contact and sharing needles. It can also be spread from mother to child during birth or breast-feeding. It is unclear why some people with HTLV-2 may develop neurological problems and other medical conditions, while others remain <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002217.htm\" target=\"_blank\">asymptomatic</a> (show no signs or symptoms) their entire lives.[7945][7946]","dateModified":"2015-01-01T10:04:00","resourceClassificationName":"Cause","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8090,"questionText":"How is human T-cell leukemia virus, type&nbsp;2 diagnosed?","answerText":"Human T-cell leukemia virus, type&nbsp;2 (HTLV-2) is usually diagnosed based on blood tests that detect <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> to the virus. However, HTLV-2 is often never suspected or diagnosed since most people never develop any signs or symptoms of the infection. Diagnosis may occur during screening for blood donation, testing performed due to a family history of the infection, or a work-up for an HTLV-2-associated medical problems.[7945][7946]","dateModified":"2015-01-01T10:12:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8091,"questionText":"How might human T-cell leukemia virus, type&nbsp;2 be treated?","answerText":"No cure or treatment exists for human T-cell leukemia virus, type&nbsp;2 (HTLV-2). Management is focused on early detection and preventing the spread of HTLV-2 to others. Screening blood doners, promoting safe sex and discouraging needle sharing can decrease the number of new infections. Mother-to-child transmission can be reduced by screening pregnant women so infected mothers can avoid breastfeeding.[7946][7945]","dateModified":"2015-01-01T10:19:00","resourceClassificationName":"Treatment","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8092,"questionText":"What is the long-term outlook for people with human T-cell leukemia virus, type 2?","answerText":"The long-term outlook (prognosis) for most people infected with human T-cell leukemia virus, type 2 (HTLV-2) is good.&nbsp;Infection with HTLV-2 is lifelong, but 95% of&nbsp;affected&nbsp;people have no signs or symptoms of the condition. Although HTLV-2 has not been definitively linked with any specific health problems, scientists suspect that some affected people may later develop neurological problems and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a> lung infections. However, HTLV-2-related health problems tend to be significantly milder than those associated with <a href=\"http://rarediseases.info.nih.gov/gard/9645/human-t-cell-leukemia-virus-type-1/resources/9\" target=\"_blank\">human T-cell leukemia virus, type 1</a>.[7946]","dateModified":"2015-01-01T10:27:00","resourceClassificationName":"Prognosis","references":[{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Human_T-cell_leukemia_virus_type_2"}